At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Fecal Microbiota Transplantation for the Treatment of Primary Sclerosing Cholangitis.
In Brief
A Phase 2 clinical trial evaluating Fecal Microbiota Transplantation for Sclerosing Cholangitis. Completed, enrolled 10 participants across 1 site.
Detailed Summary
This is an open-label single-arm pilot study to measure the safety, microbiological and clinical impacts of Fecal Microbiota Transplantation (FMT) in patients with Primary Sclerosing Cholangitis (PSC). The investigators will prospectively enroll 10 PSC patients Stage 1 and 2 who also have concurrent inflammatory bowel disease Donor Stool from one healthy donor will be obtained from OpenBiome. OpenBiome is a nonprofit 501(c)(3) organization that provides hospitals with screened, filtered, and frozen material ready for clinical use